MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Cassava Sciences Inc

Gesloten

SectorGezondheidszorg

1.38 0.73

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.34

Max

1.41

Belangrijke statistieken

By Trading Economics

Inkomsten

346K

-28M

EPS

-0.57

Werknemers

30

EBITDA

1.4M

-30M

Aanbevelingen

By TipRanks

Aanbevelingen

Sell

12 Maanden Prognose

+44.93% upside

Dividenden

By Dow Jones

Volgende Winsten

8 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-40M

80M

Vorige openingsprijs

0.65

Vorige sluitingsprijs

1.38

Nieuwssentiment

By Acuity

100%

0%

376 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Cassava Sciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 sep 2024, 10:48 UTC

Belangrijke Marktbewegers

Cassava Sciences Shares Lower Premarket on $40 Million Penalty to Settle Doctored Data Claims

28 jun 2024, 20:15 UTC

Belangrijke Marktbewegers

Cassava Sciences' Shares Down 46% After Adviser Is Indicted

27 sep 2024, 18:36 UTC

Winsten

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More -- Barrons.com

27 sep 2024, 09:15 UTC

Populaire aandelen

Stocks to Watch Friday: Bristol Myers Squibb, EchoStar, Costco -- WSJ

Peer Vergelijking

Prijswijziging

Cassava Sciences Inc Prognose

Koersdoel

By TipRanks

44.93% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 2 USD  44.93%

Hoogste 2 USD

Laagste 2 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cassava Sciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

2 ratings

0

Buy

1

Hold

1

Sell

Technische score

By Trading Central

N/A / 1.5Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Neutral Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

376 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.